Label Image (Lbl500906453)
Trulicity Injection, Solution
Product Images NDC 50090-6453
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 48 technical images submitted to the FDA as part of the official labeling for Trulicity (NDC 50090-6453). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Logo)
Qr Code (Qr V1)
Figure (Trulicity Ifu 0point75 Injection Sites Back V1)
Figure (Trulicity Ifu 0point75 Injection Sites Front V1)
Figure (Trulicity Ifu 1point5 Injection Sites Back V1)
Figure (Trulicity Ifu 1point5 Injection Sites Front V1)
Figure (Trulicity Ifu 3mg Injection Sites V1)
Figure (Trulicity Ifu 4point5mg Injection Sites V1)
Figure (Trulicity Ifu Check V1)
Exclamation (Trulicity Ifu Exclamation V1)
Figure (Trulicity Ifu Expiration Location V2)
Figure (Trulicity Ifu Inspect V1)
Locked (Trulicity Ifu Locked V1)
Figure (Trulicity Ifu Prepare V1)
Figure (Trulicity Ifu Remove V1)
Figure (Trulicity Ifu Sup 0point75 F2 V3)
Figure (Trulicity Ifu Sup 0point75 F3 V3)
Figure (Trulicity Ifu Sup 0point75 F4 V3)
Figure (Trulicity Ifu Sup 0point75 F5 V3)
Figure (Trulicity Ifu Sup 0point75 Pen Parts V3)
This appears to be a diagram or image of a medical device, possibly a syringe or injector. The device has an injection button, lock ring, indicator, and a lock/unlock feature. The device also includes a needle, clear base, and base cap. However, without more context or information it is difficult to determine the exact purpose or function of the device.*
Figure (Trulicity Ifu Sup 0point75 Pen V3)
Figure (Trulicity Ifu Sup 1point5 F2 V3)
Figure (Trulicity Ifu Sup 1point5 F3 V3)
Figure (Trulicity Ifu Sup 1point5 F4 V3)
Figure (Trulicity Ifu Sup 1point5 F5 V3)
Figure (Trulicity Ifu Sup 1point5 Pen Parts V3)
This is the description of an injection device that features a top button, a lock ring, an indicator, and a clear base with a needle cap at the end. The device can apparently be locked and unlocked for administering medicine.*
Figure (Trulicity Ifu Sup 1point5 Pen V3)
Figure (Trulicity Ifu Sup 3mg F2 V1)
Figure (Trulicity Ifu Sup 3mg F3 V1)
Figure (Trulicity Ifu Sup 3mg F4 V1)
This text provides instructions for administering an injection and indicates that the injection is complete when the gray plunger becomes visible. The origin or type of injection is not specified.*
Figure (Trulicity Ifu Sup 3mg F5 V1)
Figure (Trulicity Ifu Sup 3mg Pen Parts V1)
The text is describing a device that has a top button labeled "MR Injection". There is also a "LockRing" with an indicator that has the words "Lock" and "Unlock". The text is unclear what this device is used for, but it might be related to medicine.*
Figure (Trulicity Ifu Sup 3mg Pen V1)
Figure (Trulicity Ifu Sup 4point5 F2 V1)
Figure (Trulicity Ifu Sup 4point5 F3 V1)
Figure (Trulicity Ifu Sup 4point5 F4 V1)
This text seems to be an instruction for an injection process. The instruction suggests that the injection should be considered complete when the gray plunger is visible. The meaning of the text appears to be incomplete without any context.*
Figure (Trulicity Ifu Sup 4point5 F5 V1)
Figure (Trulicity Ifu Sup 4point5 Pen Parts V1)
This appears to be an image of a medical device with different components labeled including a top injection button, lockring, indicator, lock/unlock mechanism, medicine, clear base, bottom, needle, end base cap. The purpose of the device is not clear from the text provided.*
Figure (Trulicity Ifu Sup 4point5 Pen V1)
Figure (Trulicity Ifu Unfold V1)
Unlocked (Trulicity Ifu Unlock V1)
Figure 1 (Trulicity Pi F1 V2)
Figure 2 (Trulicity Pi F2 V2)
This text appears to be a list of drugs that have been coadministered, along with some measurements of their pharmacokinetics (PK) such as AUC and Cmax, and some ratios and confidence intervals (90%Cl). It is not clear from the text what kind of study or experiment this information comes from.*
Figure 3 (Trulicity Pi F3 V3)
Figure 4 (Trulicity Pi F4 V3)
This is a chart showing the mean HbA1c values at different levels ranging from 65 to 85. It also contains three lines that represent different dosages of TRULICITY (1.5 mg, 3mg, and 4.5 mg) over the course of 36 weeks. The chart appears to be part of a clinical study or trial.*
Figure 5 (Trulicity Pi F5 V2)
This appears to be a table with the LS mean HbA1 (%) values for different drug treatments at different time points. The drug treatments being compared are TRULIGITY 15mg, TRULIGITY 0.75mg, Exenaide, and Piacabo. The time points being compared range from post-randomization to 26 weeks after.*
Figure 6 (Trulicity Pi F6 V2)
This is a statistical report that shows the percentage of patients who experienced an event over a period of 6 years. The report compares a placebo treatment with a drug called Dulaglutide, which showed a hazard ratio of 0.88 with a 95% confidence interval of [0.79, 0.99]. No further information or context is available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
